In addition, IFN-β (p < 0.0004) and CXCL-10 (p < 0.0002) were also found to be upregulated by 4-fold upon dose-dependent treatment of AVA-NP-695 in the 4T1 tumor (Figure 6I,J). The gene discussed is CXCL10; the disease is neoplasm.